In patients with PLC, T cell responses are strongly impaired, due to a highly suppressive tumor milieu and a reactivation of tumor-specific Th1 CD4 and CD8 T cell responses is indispensable to mediate control of liver cancer progression [10]. This evidence concerns the gene CD8A and neoplasm.